SEARCH

SEARCH BY CITATION

References

  • 1
    Schnitzler L. Lésions urticariennes chroniques permanentes (érythème pétaloïde ?) Cas cliniques, n° 46 B. Journée Dermatologique d'Angers, 28 octobre 1972.
  • 2
    Schnitzler L, Schubert B, Boasson M, Gardais J, Tourmen A. Urticaire chronique, lésions osseuses, macroglobulinémie IgM: maladie de Waldenström ? 2ème présentation. Bull Soc Fr Dermatol Syphil 1974;81:363.
  • 3
    Schnitzler L, Hurez D, Verret JL. Urticaire chronique, ostéocondensation, macroglobulinémie. Cas princeps. Etude sur 20 ans. Ann Dermatol Venereol 1989;116:547550.
  • 4
    Lipsker D, Veran Y, Grunenberger F, Cribier B, Heid E, Grosshans E. The Schnitzler syndrome. Four new cases and review of the literature. Medicine (Baltimore) 2001;80:3744.
  • 5
    de Koning HD, Bodar EJ, van der Meer JW. Schnitzler Syndrome Study Group. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum 2007;37:137148.
  • 6
    Lipsker D. The Schnitzler syndrome. Orphanet J Rare Dis 2010;8:38.
  • 7
    Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR et al. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 2003;102:37593764.
  • 8
    Claes K, Bammens B, Delforge M, Evenepoel P, Kuypers D, Vanrenterghem Y. Another devastating complication of the Schnitzler syndrome: AA amyloidosis. Br J Dermatol 2008;158:182184.
  • 9
    Kieffer C, Cribier B, Lipsker D. Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature. Medicine (Baltimore) 2009;88:2331.
  • 10
    Martinez-Taboada VM, Fontalba A, Blanco R, Fernández-Luna JL. Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al. Arthritis Rheum 2005;52:22262227.
  • 11
    de Koning HD, van der Meer JW, Simon A. Comment on: Schnitzlers syndrome–exacerbation after anti-TNF treatment. Rheumatology (Oxford) 2007;46:1741.
  • 12
    Besada E, Nossent H. Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review. Clin Rheumatol 2010;29:567571.
  • 13
    Billey T, Beldjerd M, Popa L, Lassoued S. Schnitzler syndrome: a dramatic improvement with anakinra. Presse Med 2010;39:13381339.
  • 14
    Cascavilla N, D'Arena G, Dell'OLio M. Schnitzler syndrome. Br J Haematol 2008;143:152.
  • 15
    Cascavilla N, Bisceglia M, D'Arena G. Successful treatment of Schnitzler's syndrome with anakinra after failure of rituximab trial. Int J Immunopathol Pharmacol 2010;23:633636.
  • 16
    Crouch R, Akhras V, Sarkany R. Schnitzler's syndrome: successful treatment with anakinra. Australas J Dermatol 2007;48:178181.
  • 17
    Devlin LA, Wright G, Edgar JD. A rare cause of a common symptom Anakinra is effective in the urticaria of Schnitzler Syndrome: a case report. Cases J 2008;1:348.
  • 18
    Dybowski F, Sepp N, Bergerhausen HJ, Braun J. Successful use of anakinra to treat refractory Schnitzler's syndrome. Clin Exp Rheumatol 2008;26:354357.
  • 19
    Eiling E, Möller M, Kreiselmaier I, Brasch J, Schwarz T. Schnitzler syndrome: treatment failure to rituximab but response to anakinra. J Am Acad Dermatol 2007;57:361364.
  • 20
    Eiling E, Schröder JO, Gross WL, Kreiselmaier I, Mrowietz U, Schwarz T. The Schnitzler syndrome: chronic urticaria and monoclonal gammopathy—an autoinflammatory syndrome? J Dtsch Dermatol Ges 2008;6:626631.
  • 21
    Flórez AF. Gallardo Agromayor E, García-Barredo R, Landeras Alvaro RM, Gorriño Angulo M, Martínez-Taboada VM, et al. Radiological aid to clinical diagnosis of Schnitzler's syndrome: multimodality imaging approach. Clin Rheumatol 2008;27:107110.
  • 22
    Frischmeyer-Guerrerio PA, Rachamalla R, Saini SS. Remission of Schnitzler syndrome after treatment with anakinra. Ann Allergy Asthma Immunol 2008;100:617619.
  • 23
    Gilson M, Abad S, Larroche C, Dhote R. Treatment of Schnitzler syndrome with anakinra. Clin Exp Rheumatol 2007;25:931.
  • 24
    Klemmer N, Lenain P, Balguerie X, Le Loët X. Effectiveness of anti-IL1 in Schnitzler's syndrome. Joint Bone Spine 2007;74:509510.
  • 25
    Kluger N, Rivière S, Guillot B, Bessis D. Efficacy of interleukin 1 receptor antagonist (anakinra) on a refractory case of Schnitzler's syndrome. Acta Derm Venereol 2008;88:287288.
  • 26
    Larocca CA, McEvoy JW, Ellis CL, Junkins-Hopkins J, Kolb T, Baer AN et al. Schnitzler's syndrome associated with pancreatitis: a disease of IL-1 dysregulation. Clin Rheumatol 2012;31:169174.
  • 27
    Lee KY, Grattan CE. Intracostal neuralgia as a previously undescribed symptom of Schnitzler's syndrome. Br J Dermatol 2012;167:13921393.
  • 28
    Loock J, Lamprecht P, Timmann C, Mrowietz U, Csernok E, Gross WL. Genetic predisposition (NLRP3 V198M mutation) for IL-1-mediated inflammation in a patient with Schnitzler syndrome. J Allergy Clin Immunol 2010;125:500502.
  • 29
    Ryan JG, de Koning HD, Beck LA, Booty MG, Kastner DL, Simon A. IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission. J Allergy Clin Immunol 2008;121:260262.
  • 30
    Saiz E, Gálvez J, Mora A, Contreras L. Anakinra and Schnitzler's syndrome. Med Clin (Barc) 2008;130:358359.
  • 31
    Schneider SW, Gaubitz M, Luger TA, Bonsmann G. Prompt response of refractory Schnitzler syndrome to treatment with anakinra. J Am Acad Dermatol 2007;56(5 Suppl):S120S122.
  • 32
    Schuster C, Kränke B, Aberer E, Arbab E, Sturm G, Aberer W. Schnitzler syndrome: response to anakinra in two cases and review of the literature. Int J Dermatol 2009;48:11901194.
  • 33
    Sokumbi O, Drage LA, Peters MS. Clinical and histopathologic review of Schnitzler syndrome: the Mayo Clinic experience (1972–2011). J Am Acad Dermatol 2012;67:12891295.
  • 34
    Szturz P, Adam Z, Hájek R, Mayer J. Successful anakinra therapy in 2 patients with Schnitzler syndrome. Onkologie 2011;34:265268.
  • 35
    Szturz P, Adam Z, Sedivá A, Fojtík Z, Corbová D, Neubauer J et al. Schnitzler syndrome: diagnostics and treatment. Klin Onkol 2011;24:271277.
  • 36
    Terpos E, Asli B, Chistoulas D, Brouet JC, Kastritis E, Rybojad M et al. Increased Angiogenesis and Enhanced Bone Formation in Patients with IgM Monoclonal Gammopathy and Urticarial Skin Rash: New Insight into the Biology of the Schnitzler Syndrome. Haematologica 2012;97:16991703.
  • 37
    Thonhofer R, Uitz E, Graninger W. Schnitzler's syndrome–exacerbation after anti-TNF treatment. Rheumatology (Oxford) 2007;96:10411042.
  • 38
    Tinazzi E, Puccetti A, Patuzzo G, Sorleto M, Barbieri A, Lunardi C. Schnitzler syndrome, an autoimmune-autoinflammatory syndrome: report of two new cases and review of the literature. Autoimmun Rev 2011;10:404409.
  • 39
    Treudler R, Kauer F, Simon JC. Striking effect of the IL-1 receptor antagonist Anakinra in chronic urticarial rash with polyclonal increase in IgA and IgG. Acta Derm Venereol (Stockh) 2007;87:280281.
  • 40
    van Deuren M, Kroot JJ, Swinkels DW. Time-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient with Schnitzler's syndrome treated with IL-1 receptor antagonist. Haematologica 2009;94:12971300.
  • 41
    Vandenhende MA, Bentaberry F, Morlat P, Bonnet F. Anakinra: an effective treatment in the Schnitzler syndrome. Joint Bone Spine 2011;78:636637.
  • 42
    Volz T, Wölbing F, Fischer J, Braun M, Maggoschitz I, Schaller M et al. Dermal Interleukin-1 Expression and Effective and Long-lasting Therapy with Interleukin-1 Receptor Antagonist Anakinra in Schnitzler Syndrome. Acta Derm Venereol 2012;92:393394.
  • 43
    Wastiaux H, Barbarot S, Gagey-Caron V, Berthelot JM, Hamidou M, Stalder JF. Schnitzler syndrome: a dramatic improvement with anakinra. J Eur Acad Dermatol Venereol 2009;23:8587.
  • 44
    Asli B, Bienvenu B, Cordoliani F, Brouet JC, Uzunhan Y, Arnulf B et al. Chronic urticaria and monoclonal IgM gammopathy (Schnitzler syndrome): report of 11 cases treated with pefloxacin. Arch Dermatol 2007;143:10461050.
  • 45
    Kastritis E, Katoulis A, Terpos E, Panayiotides I, Gavriatopoulopu M, Dimopopoulos MA. Schnitzler's syndrome: increased levels of bone formation and angiogenesis factors are reduced after successful pefloxacin treatment. Clin Lymphoma Myeloma 2008;8:359362.
  • 46
    Fischer-Betz R, Specker C, Schneider M. Successful outcome of two pregnancies in patients with adult-onset Still's disease treated with IL-1 receptor antagonist (anakinra). Clin Exp Rheumatol 2011;29:10211023.
  • 47
    Asli B, Brouet JC, Fermand JP. Spontaneous remission of Schnitzler syndrome. Ann Allergy Asthma Immunol 2011;107:8788.
  • 48
    de Koning HD, Schalkwijk J, van der Meer JW, Simon A. Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome. J Allergy Clin Immunol 2011;128:13521354.
  • 49
    Krause K, Weller K, Stefaniak R, Wittkowski H, Altrichter S, Siebenhaar F et al. Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study. Allergy 2012;67:943950.
  • 50
    Krause K, Feist E, Fiene M, Kallinich T, Maurer M. Complete remission in 3 of 3 anti-IL-6-treated patients with Schnitzler syndrome. J Allergy Clin Immunol 2012;129:848850.